checkAd

     105  0 Kommentare PMD Device Solutions Publishes 2023 Annual Report

    STOCKHOLM, SWEDEN / ACCESSWIRE / April 26, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions (PMDS) announces today that the company's annual report for 2023 is published and available at the website www.pmd-solutions.com"In …

    STOCKHOLM, SWEDEN / ACCESSWIRE / April 26, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions (PMDS) announces today that the company's annual report for 2023 is published and available at the website www.pmd-solutions.com

    "In fiscal year 2023, PMDS delivered exceptional results, evidencing a robust growth trajectory with a remarkable surge in Annual Recurring Revenue by a staggering 116% compared to 2022 figures. This achievement translates to a substantial 39 MSEK, representing an impressive 39% of our ambitious 2026 financial milestone. The successful listing on Nasdaq First North signifies a pivotal milestone, reinforcing our strategic objective of reaching profitability in 2024. Moving forward, our focused initiatives entail the continued expansion of RespiraSense within the UK market and the strategic acquisition of Qorum Partners in the US. These strategic moves underscore our unwavering commitment to driving sustained value creation for our shareholders." - Myles Murray, CEO

    Information about PMDS

    PMD Device Solutions AB develops and sells medical products for respiratory monitoring in both the hospital and homecare setting. Its primary product is RespiraSense, a solution used for monitoring respiratory rate to support the detection of patient deterioration early and to avoid preventable respiratory failure and adverse patient outcomes. RespiraSense is, to the Company's knowledge, the world's only continuous, motion-tolerant respiratory rate monitor delivering class-leading reliability in measuring respiratory rate. RespiraSense is a novel technology that is commercialised in Europe, the UK, and FDA cleared in the US. The company's shares are listed on Nasdaq First North Growth Market (STO: PMDS).

    For additional information, please contact

    Myles Murray, CEO
    Phone: +353 86 887 4994
    E-mail: myles@pmd-solutions.com & for general enquiries investor.relations@pmd-solutions.com
    The Company's Certified Adviser is Redeye.

    Attachments

    PMD Device Solutions 2023 Annual Report

    SOURCE: PMD Device Solutions



    View the original press release on accesswire.com


    The PMD Device Solutions Stock at the time of publication of the news with a fall of -5,11 % to 0,650EUR on Frankfurt stock exchange (26. April 2024, 08:06 Uhr).


    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen

    Verfasst von Accesswire
    PMD Device Solutions Publishes 2023 Annual Report STOCKHOLM, SWEDEN / ACCESSWIRE / April 26, 2024 / PMD Device Solutions (FRA:8T0)(STO:PMDS) PMD Device Solutions (PMDS) announces today that the company's annual report for 2023 is published and available at the website www.pmd-solutions.com"In …